Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective Study
CompletedOBSERVATIONAL
Enrollment
70
Participants
Timeline
Start Date
December 31, 2011
Primary Completion Date
December 31, 2015
Study Completion Date
March 31, 2016
Conditions
Exposure to Hepatitis B Virus
Trial Locations (1)
Unknown
Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
All Listed Sponsors
lead
The University of Hong Kong
OTHER
NCT01502397 - Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective Study | Biotech Hunter | Biotech Hunter